Illustris Pharmaceuticals' Unattributed Round

Illustris Pharmaceuticals raised a round of funding on March 03, 2017.

Illustris is a privately held bio-development company specializing in its proprietary delivery technology. The Illustris delivery technology both enables the delivery of large molecules through tissue…

Articles about Illustris Pharmaceuticals' Unattributed Round: